Aminocaproic Acid Uses, Dosage, Side Effects and Interactions
Amicar
Amicar is an aminocaproic acid brand from before 1982 that came as an injection, an oral solution and a tablet. It is not in the FDA’s directory today; generic aminocaproic acid is.
Aminocaproic acid is an anti-fibrinolytic medicine (it slows the breakdown of blood clots) used to help stop bleeding caused by excess clot breakdown, available as an injection, an oral solution and tablets.
Quick links
Ask Anything About Aminocaproic AcidType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Aminocaproic Acid in Short
- Drug class Antifibrinolytic Agent How the FDA classifies it
What it treatsAminocaproic acid helps control bleeding when fibrinolysis (the body’s natural breakdown of blood clots) is contributing to it. In life-threatening situations, other emergency measures, such as blood product transfusions, may also be needed.
- How you get it Prescription only
- Comes asTablet, oral solution and injectionAvailable strengths
Tablet (by mouth)
- 500 mg
- 1000 mg
Oral solution (by mouth)
- 0.25 g/mL
Injection (into a vein)
- 250 mg/mL
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- What pharmacies pay
- Generic$2.48 to $8.30 a tablet
- Injections: no national price found
The pharmacy’s own cost, national average. Not your price See every price+ 1 more price detailShow fewer price details
- Oral solution, generic: $0.58 per mL
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Aminocaproic acid (Amicar) is an older antifibrinolytic, a drug that slows the body’s breakdown of blood clots, used under specialist direction to help control bleeding driven by that breakdown, such as after heart surgery, in cirrhosis or with certain cancers; it has been on the U.S. market since about 1964, and FDA-approved generics are listed. Short courses are usually well tolerated; nausea, diarrhea, headache and dizziness are the usual complaints. Its main risk is an unwanted clot, so chest pain, sudden shortness of breath or limb pain needs emergency care. Rarely, longer use damages muscle, so report new muscle pain, weakness or unusual fatigue right away.
Key Takeaways From the HelloPharmacist Team
- Expect a larger amount in the first hour, then a smaller amount every hour, for about 8 hours or until bleeding is controlled.
- Get help promptly for dark, cola-colored urine or passing much less urine, since clots or muscle damage can block or injure the kidneys.
- On longer courses, expect blood tests for CPK, a muscle enzyme, because the drug is stopped if that level rises.
- Ask which version your insurance covers, since FDA-approved generic versions of Amicar are listed in the FDA directory.
Patient Information Guide for Aminocaproic Acid
What It’s Used For
Aminocaproic acid is used to help control bleeding linked to excess clot breakdown.
- Bleeding after heart surgery or portacaval shunt surgery
- Aplastic anemia-related blood disorders
- Abruptio placentae (life-threatening)
- Hepatic cirrhosis
- Cancers of the prostate, lung, stomach and cervix
- Blood in the urine after prostate or kidney surgery, or from polycystic or cancerous genitourinary disease
- Aminocaproic Acid Injection: urinary fibrinolysis complications after severe trauma, anoxia and shock
How It Works
Aminocaproic acid mainly blocks plasminogen activators, the substances that begin clot breakdown. It also has a smaller effect on antiplasmin activity. By slowing clot breakdown, it helps clots hold so bleeding can be controlled.
Drug Class
Drug Class
- Antifibrinolytic Agent
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Antifibrinolytic Agent
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)None listed for Aminocaproic Acid in the FDA’s index.
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)- Decreased Fibrinolysis
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Aminocaproic Acid in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Amino acids
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
The injection is given by a healthcare professional as a diluted intravenous infusion. The tablets and oral solution are taken by mouth.
- For acute bleeding, a larger amount is used in the first hour, then a smaller hourly amount.
- Treatment usually lasts about 8 hours or until bleeding is controlled.
- Follow your prescriber and the product label.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Aminocaproic Acid Taken by Mouth
Bleeding caused by too much clot breakdown
Acute bleeding syndromes due to elevated fibrinolytic activity, first hour of treatment (tablets or oral solution) Starting dose 5 g (5 tablets of 1,000 mg, or 10 tablets of 500 mg, or 20 milliliter of oral solution) in the first hour
- 5 aminocaproic acid 1,000 mg tablets or 10 aminocaproic acid 500 mg tablets (5 g) or 20 milliliter of aminocaproic acid oral solution (5 g) during the first hour of treatment
Acute bleeding syndromes due to elevated fibrinolytic activity, continuing dose after the first hour (tablets or oral solution) Dose 1,000 mg
- 1 aminocaproic acid 1,000 mg tablet or 2 aminocaproic acid 500 mg tablets (1 g) or 5 milliliter of aminocaproic acid oral solution (1.25 g) per hour, ordinarily continued for about 8 hours or until the bleeding situation has been controlled
Aminocaproic Acid Injection
Bleeding caused by too much clot breakdown
Acute bleeding syndromes due to elevated fibrinolytic activity, first hour of treatment (intravenous infusion) Starting dose 16 to 20 mL (4 to 5 g) in 250 mL of diluent by infusion in the first hour
- 16 to 20 mL (4 to 5 g) of Aminocaproic Acid Injection, USP in 250 mL of diluent by infusion during the first hour of treatment
Good to know
Rapid injection undiluted into a vein is not recommended
Acute bleeding syndromes due to elevated fibrinolytic activity, continuing infusion after the first hour Usual dose 4 mL (1 g) per hour in 50 mL of diluent
- 4 mL (1 g) per hour in 50 mL of diluent, ordinarily continued for about 8 hours or until the bleeding situation has been controlled
Side Effects
The label lists these effects:
Common side effects
- Nausea, vomiting or diarrhea
- Abdominal pain
- Headache
- Dizziness
- Swelling (edema)
- Malaise (feeling unwell)
- Rash or itching
- Stuffy nose or watery eyes
When to get medical help
- Muscle pain, weakness or fatigue, especially with long-term use, which can signal muscle damage
- Dark or cola-colored urine or reduced urination, which can signal kidney problems
- Signs of an allergic reaction, such as rash, trouble breathing or swelling
- Signs of a blood clot, such as chest pain, sudden shortness of breath or limb pain
- Seizures, confusion, hallucinations or fainting
- Very slow heartbeat or low blood pressure
Warnings and Precautions
- Do not use with an active clotting process. The oral solution must not be used in DIC without heparin.
- It can cause blockage in the kidneys and ureters in upper urinary tract bleeding.
- Long-term use can rarely cause muscle damage. CPK should be monitored, and treatment stopped if it rises.
- Injection contains benzyl alcohol, which is dangerous for premature newborns.
Before You Start
- Active intravascular clotting or DIC
- Bleeding from the upper urinary tract
- Kidney problems
- Muscle, heart or liver problems
- Premature newborns (benzyl alcohol in the injection)
Overdose
Overdose effects have ranged from no reaction to low blood pressure to severe acute kidney failure that led to death. Seizures have also been reported. No specific treatment is known, but the drug may be removed by hemodialysis and possibly peritoneal dialysis.
Half-Life and How Your Body Processes It
Taken by mouth, it is absorbed completely, with peak blood levels in about 1.2 hours. It spreads through the body and is cleared mainly by the kidneys, with about 65% passing unchanged in urine. The half-life is about 2 hours. Clearance falls markedly in severe kidney failure.
Storage
Store at 20° to 25°C (68° to 77°F) ; Dispense in Tight Containers.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Aminocaproic Acid Drug Interactions
Aminocaproic Acid: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Aminocaproic Acid — the kind of thing our pharmacy team would talk through with you at the counter.
What is aminocaproic acid used for?
How do I take aminocaproic acid?
What side effects should I expect?
Who should not take aminocaproic acid?
Can aminocaproic acid cause muscle problems?
How long does aminocaproic acid stay in the body?
Is aminocaproic acid available over the counter?
When was aminocaproic acid first available?
Who makes aminocaproic acid?
What is the brand name of aminocaproic acid?
What is the generic name of Amicar?
What drug class is aminocaproic acid?
Is there a generic version of aminocaproic acid?
What strengths does aminocaproic acid come in?
How much does aminocaproic acid cost?
Is there a aminocaproic acid shortage?
Where can I read the aminocaproic acid prescribing information (package insert)?
Is aminocaproic acid gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Aminocaproic Acid
Skip the scrolling. Ask in your own words and get an answer from Aminocaproic Acid’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Aminocaproic Acid’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Aminocaproic Acid on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, usually within a day.Aminocaproic Acid Forms and Strengths (How It Comes)
Aminocaproic Acid comes in 3 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Aminocaproic Acid inactive ingredients by manufacturer.
Tablet
How this form is used
- Aminocaproic acid tablets help control bleeding when excess clot breakdown contributes to it.
- Aminocaproic acid tablets are taken by mouth, with a larger amount in the first hour, then an hourly amount, usually for about 8 hours or until bleeding is controlled.
Oral solution
How this form is used
- Aminocaproic Acid oral solution helps control bleeding when excess clot breakdown contributes to it.
- Aminocaproic Acid oral solution is usually given in a larger amount in the first hour, then smaller amounts hourly, for about 8 hours or until bleeding is controlled.
- Aminocaproic Acid oral solution must not be used in DIC without heparin.
Injection
How this form is used
- Aminocaproic Acid Injection helps control bleeding when excess clot breakdown contributes to it.
- Aminocaproic Acid Injection is also linked to urinary fibrinolysis complications after severe trauma, anoxia and shock.
- Aminocaproic Acid Injection is given by infusion in a compatible intravenous fluid.
- Rapid undiluted injection of Aminocaproic Acid Injection into a vein is not recommended.
- Aminocaproic Acid Injection contains benzyl alcohol, which is a concern for premature newborns.
Aminocaproic Acid on the U.S. Market: Products, Makers and Brands
How Aminocaproic Acid appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
23 companies list 37 Aminocaproic Acid product records with the FDA, mostly as tablet, oral solution, injection; the earliest marketing or approval year on record is 1964.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (8) · Unfinished solution (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Aminocaproic Acid Is Used (Medicaid Data)
How many Aminocaproic Acid prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Aminocaproic Acid prescribed? Of the 1,666 medications we measure, Aminocaproic Acid ranks #1,054 by Medicaid prescriptions — more than 37% of them.
Utilization by Aminocaproic Acid product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
6-aminocaproic acid 250 MG/ML Oral Solution Most dispensed
5 of 19 listed NDCs had Medicaid claims. RxNorm 582299
6-aminocaproic acid 500 MG Oral Tablet
4 of 17 listed NDCs had Medicaid claims. RxNorm 197351
6-aminocaproic acid 1000 MG Oral Tablet
3 of 10 listed NDCs had Medicaid claims. RxNorm 476271
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 12 of the 46 listed Aminocaproic Acid NDCs had Medicaid claims.
Compare Aminocaproic Acid Products
A representative set of FDA-listed product records for Aminocaproic Acid — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 250 mg/mL | Intravenous | American Regent, Inc. × 2 listings | ANDA | View NDC → |
| 250 mg/mL | Intravenous | Civica, Inc. | ANDA | View NDC → |
| 250 mg/mL | Intravenous | Henry Schein, Inc. | ANDA | View NDC → |
| 250 mg/mL | Intravenous | Hospira, Inc. | ANDA | View NDC → |
| 250 mg/mL | Intravenous | Medical Purchasing Solutions, LLC × 2 listings | ANDA | View NDC → |
| 💊Oral solution | ||||
| 0.25 g/mL | Oral | Amneal Pharmaceuticals NY LLC | ANDA | View NDC → |
| 0.25 g/mL | Oral | Apozeal Pharmaceuticals Inc. | ANDA | View NDC → |
| 0.25 g/mL | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 0.25 g/mL | Oral | Biocon Pharma Inc. | ANDA | View NDC → |
| 0.25 g/mL | Oral | Bpi Labs Llc | ANDA | View NDC → |
| 0.25 g/mL | Oral | Bryant Ranch Prepack | ANDA | View NDC → |
| 0.25 g/mL | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.25 g/mL | Oral | Carnegie Pharmaceuticals, LLC | ANDA | View NDC → |
| 0.25 g/mL | Oral | Florida Pharmaceutical Products, LLC | ANDA | View NDC → |
| 0.25 g/mL | Oral | Hikma Pharmaceuticals USA Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 0.25 g/mL | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| 0.25 g/mL | Oral | TruPharma LLC | ANDA | View NDC → |
| 0.25 g/mL | Oral | Vitruvias Therapeutics | ANDA | View NDC → |
| 💊Tablet | ||||
| 500 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 500 mg | Oral | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 500 mg | Oral | Biocon Pharma Inc. | ANDA | View NDC → |
| 1000 mg | Oral | Biocon Pharma Inc. | ANDA | View NDC → |
| 500 mg | Oral | Carnegie Pharmaceuticals, LLC | ANDA | View NDC → |
| 1000 mg | Oral | Carnegie Pharmaceuticals, LLC | ANDA | View NDC → |
| 1000 mg | Oral | Hikma Pharmaceuticals USA Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 500 mg | Oral | Kesin Pharma Corporation | ANDA | View NDC → |
| 500 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 500 mg | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| 1000 mg | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| 500 mg | Oral | Puracap Laboratories Llc Dba Blu Pharmaceuticals | ANDA | View NDC → |
| 1000 mg | Oral | Puracap Laboratories Llc Dba Blu Pharmaceuticals | ANDA | View NDC → |
| 500 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 1000 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Vitruvias Therapeutics | ANDA | View NDC → |
| 1000 mg | Oral | Vitruvias Therapeutics | ANDA | View NDC → |
Showing 37 of 37 products — FDA National Drug Code Directory. See every product, package size and price: browse all 37 Aminocaproic Acid NDCs →
Aminocaproic Acid Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Aminocaproic Acid — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Aminocaproic Acid in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Aminocaproic Acid FDA Approval History
How Aminocaproic Acid went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Aminocaproic Acid Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list one Aminocaproic Acid recall since July 2021. It is still ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- AMINAOCAPROIC ACID INJECTION, USP, 250 mg/mL (5 g/20 mL), packaged in a) 20 mL MULTIPLE DOSE VIAL FOR IV INFUSION (NDC 0517-9120-01), and b) 25x20 mL MULTIPLE DOSE VIALS (NDC 0517-9120-25), Rx Only,… Lots: Lot #: 24299, Exp. Date: 8/31/2026. FDA record D-0794-2026 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 12, 2026.
Aminocaproic Acid in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 4
- Strengths
- 5
- Forms in current FDA listings
- 4 of 4
RxCUI 99 -
Dose form (SCDF) Injectable SolutionIn current FDA listings
RxCUI 379238Its strength (SCD)-
250 mg/mL
RxCUI 238719
-
250 mg/mL
-
Dose form (SCDF) InjectionIn current FDA listings
RxCUI 1718759Its strength (SCD)-
20 mL 6-aminocaproic acid 250 mg/mL
RxCUI 1718760
-
20 mL 6-aminocaproic acid 250 mg/mL
-
Dose form (SCDF) Oral SolutionIn current FDA listings
RxCUI 582298Its strength (SCD)-
250 mg/mL
RxCUI 582299
-
250 mg/mL
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Aminocaproic Acid Supply and Shortage Status
Whether Aminocaproic Acid is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Aminocaproic Acid Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Aminocaproic Acid: the national average from CMS’s weekly NADAC survey, as of Nov 11, 2026. It is the pharmacy’s cost, not your price at the counter.
No national price was found for Aminocaproic Acid injections, so the prices below are for the tablets and oral solution only.
How the Pharmacy Price Has Changed
Pick a form and a strength to see how its price has changed since Apr 2024.
For the generic 500 mg tablet, pharmacies paid an average of $2.48 per tablet as of Nov 11, 2026, down 30% from $3.53 a year earlier.
- What pharmacies pay now
- $2.48
- per tablet, as of Nov 11, 2026
- Last 4 weeks
- Down 1.8%
- from $2.52 on Oct 14, 2026
- Last 12 months
- Down 30%
- from $3.53 on Nov 12, 2025
- Lowest and highest since Apr 2024
- $1.78 to $3.90
- per tablet
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $2.48 |
| Oct 2026 | $2.48 |
| Sep 2026 | $2.52 |
| Aug 2026 | $2.68 |
| Jul 2026 | $2.73 |
| Jun 2026 | $2.86 |
| May 2026 | $3.12 |
| Apr 2026 | $3.25 |
| Mar 2026 | $3.28 |
| Feb 2026 | $3.43 |
| Jan 2026 | $3.74 |
| Dec 2025 | $3.90 |
| Nov 2025 | $3.81 |
| Oct 2025 | $3.53 |
| Sep 2025 | $3.50 |
| Aug 2025 | $3.50 |
| Jul 2025 | $3.50 |
| Jun 2025 | $2.48 |
| May 2025 | $2.26 |
| Apr 2025 | $2.15 |
| Mar 2025 | $2.14 |
| Feb 2025 | $2.08 |
| Jan 2025 | $2.01 |
| Dec 2024 | $1.99 |
| Nov 2024 | $1.90 |
| Oct 2024 | $2.09 |
| Sep 2024 | $2.05 |
| Aug 2024 | $2.05 |
| Jul 2024 | $2.05 |
| Jun 2024 | $2.49 |
| May 2024 | $2.22 |
| Apr 2024 | $1.78 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Tablet · Oral | 500 mg | Generic | $2.48 per tablet | NDC details & price history |
| Tablet · Oral | 1000 mg | Generic | $8.30 per tablet | NDC details & price history |
| Oral solution · Oral | 0.25 g/mL | Generic | $0.581 per mL | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Aminocaproic Acid Brand Names
Aminocaproic Acid has one brand name on record: Amicar. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Aminocaproic Acid: Manufacturers and Labelers
23 companies list Aminocaproic Acid products with the FDA. By number of product records, the largest are Biocon Pharma Inc., Carnegie Pharmaceuticals, LLC, Novadoz Pharmaceuticals LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Aminocaproic Acid Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Hikma Pharmaceuticals USA Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →